Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Movies Merits
Sign In Sign Up
Theme Switcher
Night Mode
Sponsored
Novo Nordisk Challenges Pfizer in a High-Stakes Battle for Metsera
The global obesity drug market has erupted into a fierce competition following the Pfizer Metsera acquisition, which has now drawn a bold counteroffer from Novo Nordisk. What began as a quiet business move has escalated into an all-out bidding war after Novo Nordisk made an unsolicited $9 billion proposal to purchase Metsera—just days after Pfizer’s initial announcement. This...
0 Comments ·0 Shares ·56 Views ·0 Reviews
Please log in to like, share and comment!
Sponsored
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsored
Sponsored